Showing results (121-130 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|July 14, 2016
Severe dyslipidemia and immune activation in HIV patients with dysglycemiaChangzhong Jin, Shujing Ji, Tiansheng Xie, et al.
HIV Clinical Trials|February 20, 2016
Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamideNicolas A Margot, Kathryn M Kitrinos, Marshall Fordyce, et al.
HIV Clinical Trials|February 23, 2016
Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance ProfilesFrederic Crouzat, Anita C Benoit, Colin Kovacs, et al.
HIV Clinical Trials|February 23, 2016
Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT StudyDanielle P Porter, Jonathan Toma, Yuping Tan, et al.
HIV Clinical Trials|February 27, 2016
Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trialEdgar Turner Overton, Pablo Tebas, Bruce Coate, et al.
HIV Clinical Trials|October 18, 2017
HIV prevention trial design in an era of effective pre-exposure prophylaxisAmy Cutrell, Deborah Donnell, David T Dunn, et al.
HIV Clinical Trials|December 23, 2017
Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trialsFelix G Mhlanga, Lisa Noguchi, Jennifer E Balkus, et al.
HIV Clinical Trials|May 18, 2018
CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve menLing Luo, Yang Han, Xiaojing Song, et al.
HIV Clinical Trials|June 11, 2017
HIV-coinfected patients respond worse to direct-acting antiviral-based therapy against chronic hepatitis C in real life than HCV-monoinfected individuals: a prospective cohort studyKarin Neukam, Luis E Morano-Amado, Antonio Rivero-Juárez, et al.
HIV Clinical Trials|November 25, 2005
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES)S H Lowe, A M J Wensing, E A M Hassink, et al.
Pageof 68